New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 7, 2014
12:16 EDTTEVATeva announces launch of generic Xeloda
Teva Pharmaceuticals (TEVA) announced the launch of the generic equivalent to Xeloda Tablets, 150 MG and 500 MG, in the United States. Xeloda is marketed by Genentech, a unit of Roche (RHHBY) in the United States. Teva was the first to receive approval on its ANDA from the U.S. FDA on September 16, 2013 and is launching per a settlement agreement. Xeloda Tablets, 150 MG and 500 MG had annual sales of approximately $754M in the United States, according to IMS data as of December 2013.
News For TEVA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 20, 2014
06:28 EDTTEVAAllergan price target raised to $210 from $190 at Citigroup
Subscribe for More Information
October 14, 2014
11:23 EDTTEVABIND Therapeutics and The Conference Forum hold a conference
Subscribe for More Information
11:19 EDTTEVATeva upgraded to Buy from Hold at Standpoint Research

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use